Bioline Rx Ltd ADR [BLRX] stock prices are up 3.88% to $0.43 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The BLRX shares have gain 5.21% over the last week, with a monthly amount drifted -15.62%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Bioline Rx Ltd ADR [NASDAQ: BLRX] stock has seen the most recent analyst activity on May 18, 2017, when Maxim Group upgraded its rating to a Buy and also boosted its price target to $3 from $1. Previously, Rodman & Renshaw started tracking the stock with Buy rating on February 13, 2017, and set its price target to $3. On August 12, 2016, downgrade downgraded it’s rating to Hold and revised its price target to $1 on the stock. Maxim Group reiterated its Buy rating and decreased its price target to $4 on August 17, 2015. ROTH Capital reiterated its recommendation of a Buy and reduced its price target to $7 on July 27, 2015. JMP Securities started tracking with a Mkt Outperform rating for this stock on June 22, 2015, and assigned it a price target of $5.
The stock price of Bioline Rx Ltd ADR [BLRX] has been fluctuating between $0.39 and $1.93 over the past year. Bioline Rx Ltd ADR [NASDAQ: BLRX] shares were valued at $0.43 at the most recent close of the market.
Analyzing the BLRX fundamentals
Gross Profit Margin for this corporation currently stands at 0.62% with Operating Profit Margin at -2.04%, Pretax Profit Margin comes in at -1.77%, and Net Profit Margin reading is -1.77%. To continue investigating profitability, this company’s Return on Assets is posted at -0.47, Equity is -2.26 and Total Capital is -1.02. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 2.14.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.4059 points at the first support level, and at 0.3856 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.4375, and for the 2nd resistance point, it is at 0.4488.
Ratios To Look Out For
It’s worth pointing out that Bioline Rx Ltd ADR [NASDAQ:BLRX]’s Current Ratio is 1.61. As well, the Quick Ratio is 1.49, while the Cash Ratio is 0.32. Considering the valuation of this stock, the price to sales ratio is 2.00, the price to book ratio is 2.44.
